搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
44 分钟
Surgeon catches cancer from patient for 'first time in history' during operation
The procedure was being carried out on a 32-year-old man from Germany - who was suffering from a rare type of cancer and was ...
18 小时
on MSN
11-Year-Old's Brain Tumor Discovered After Roller Coaster Ride: 'We Found It Before It Spread'
Connie Campbell started showing symptoms of a then-undetected medulloblastoma just two days after riding a roller coaster ...
1 天
on MSN
How a surgeon caught cancer from a patient he was operating on
It has happened, for example, that cancer cells from an organ donor have caused cancer to grow in the recipient. Usually a ...
Live Science on MSN
3 天
Diagnostic dilemma: A surgeon accidentally transplanted a tumor into his own hand
In an unusual case, a surgeon developed a cancerous lump on his hand that stemmed from an injury he sustained while performing surgery.
LBC
1 天
Surgeon 'catches' cancer after operating on patient in first-of-its-kind case
A surgeon has been diagnosed with cancer after operating on a 32-year-old man from Germany who was diagnosed with a rare form ...
Vanguard
7 小时
Surgeon contracts CANCER from patient in first-of-its-kind case
A surgeon accidentally contracted cancer from a patient in a first of its kind occurrence. The patient, a 32-year-old man ...
7 天
on MSN
Isabella and her twin sister Sophia shared photos from the sunny Bahamas
One of northern Gaza’s last functioning hospitals, Kamal Adwan in Beit Lahia, is “suffering from a stifling siege,” Gaza's ...
Pharmaceutical Technology
4 天
PTS-500 by Gongwin Biopharm for Malignant Pleural Effusion: Likelihood of Approval
PTS-500 is under clinical development by Gongwin Biopharm and currently in Phase II for Malignant Pleural Effusion.
Pharmaceutical Technology
4 天
BXQ-350 by Bexion Pharmaceuticals for Malignant Glioma: Likelihood of Approval
BXQ-350 is under clinical development by Bexion Pharmaceuticals and currently in Phase II for Malignant Glioma.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈